Peter A Thompson Insider Trading $PRVL Prevail Therapeutics Inc.
Get free email notifications about insider trading for Peter A Thompson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).
Peter A Thompson in Prevail Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Peter A Thompson: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter A Thompson in Prevail Therapeutics Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Sell | U | 0.00 | 13,822,463 | 0 | 0 | 13.8 M to 0 (-100.00 %) |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,011,499 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 3,099,612 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 6,399,000 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Buy | P | 17.00 | 882,352 | 14,999,984 | 13,822,463 | 12.9 M to 13.8 M (+6.82 %) |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Buy | C | 0.00 | 10,510,111 | 0 | 12,940,111 | 2.4 M to 12.9 M (+432.51 %) |
Page: 1